SVF Endurance (Cayman) Ltd (CIK 1782338) reported 22 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-12-03). Recent activity: Sell VIR (191,854 shares), Sell VIR (127,938 shares), Sell VIR (61,493 shares), Sell VIR (227,803 shares), Sell VIR (235,971 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-03 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 191,854 | $1.1M |
| 2025-12-01 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 127,938 | $817,524 |
| 2025-12-01 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 61,493 | $396,015 |
| 2025-11-26 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 227,803 | $1.4M |
| 2025-11-26 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 235,971 | $1.5M |
| 2025-10-30 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 24,453 | $158,944 |
| 2025-10-30 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 100 | $649 |
| 2025-10-28 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 46,696 | $278,308 |
| 2025-10-28 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 66,403 | $401,738 |
| 2025-10-24 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 144,266 | $887,236 |
| 2025-10-24 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 154,383 | $924,754 |
| 2025-10-22 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 220,535 | $1.4M |
| 2025-10-22 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 109,675 | $690,952 |
| 2025-10-17 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 16,671 | $101,193 |
| 2025-10-17 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 12,844 | $78,348 |
| 2025-10-14 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 249,060 | $1.5M |
| 2025-10-14 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 2,300 | $13,984 |
| 2025-10-09 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 72,133 | $403,945 |
| 2025-10-09 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 466,242 | $2.8M |
| 2025-10-07 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 450,342 | $2.5M |
| 2025-10-07 | Vir Biotechnology, Inc. (VIR) | Insider | Sell | 73,955 | $420,804 |
| 2025-03-26 | Compass, Inc. (COMP) | Insider | Sell | 10.0M | $91.5M |
Source: SEC Form 4 filings · as of 2025-12-03